1037082-28-2

Basic information

• Product Name: 1-(2-bromo-5-nitrophenyl)-N-methylmethanamine
• Synonyms: 1-(2-bromo-5-nitrophenyl)-N-methylmethanamine
• CAS NO: 1037082-28-2
• Molecular Weight: 245.076
• Mol File: 1037082-28-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1-(2-bromo-5-nitrophenyl)-N-methylmethanamine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-bromo-5-nitrophenyl)-N-methylmethanamine(1037082-28-2)
• EPA Substance Registry System: 1-(2-bromo-5-nitrophenyl)-N-methylmethanamine(1037082-28-2)

Safety Data

• Hazardous Substances Data: 1037082-28-2(Hazardous Substances Data)

Usage

General Description

1-(2-bromo-5-nitrophenyl)-N-methylmethanamine is a chemical compound with the molecular formula C7H8BrN3O2. It is a derivative of N-methylmethanamine, which is a simple organic compound. The presence of a bromo and nitro group in the chemical structure makes it a potentially reactive and toxic compound. It can be used in organic synthesis and pharmaceutical research but it should be handled with caution due to its potential health hazards. The compound's properties and potential applications make it a subject of interest in the field of organic chemistry and medicinal chemistry.

Upstream product

• 943-14-6 2-bromo-5-nitrobenzoic acid 
• 80887-01-0 2-bromo-5-nitrobenzoyl chloride 
• 84459-32-5 2-bromo-5-nitrobenzaldehyde 
• 6630-33-7 ortho-bromobenzaldehyde 
• 74-89-5 methylamine 
• 373622-95-8 2-bromo-N-methoxy-N-methyl-5-nitrobenzamide 

Downstream Products

• 1037082-29-3 tert-butyl (2-bromo-5-nitrobenzyl)(methyl)carbamate 
• 1329171-58-5 benzyl 2-bromo-5-nitrobenzyl(methyl)carbamate 

Relevant articles and documents

Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex

Inhibitors of the tissue factor (TF)/factor VIIa complex (TF-FVIIa) are promising novel anticoagulants which show excellent efficacy and minimal bleeding in preclinical models. Starting with an aminoisoquinoline P1-based macrocyclic inhibitor, optimizatio

PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS

The present invention relates to compounds that are useful as inhibitors of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer.